Study of the antimicrobial and fungicidal activity of thiotriazoline and decamethoxinum as a potentially new model mixture for use of the oral mucosa
DOI:
https://doi.org/10.14739/2409-2932.2020.3.216197Keywords:
oral mucosa, pathological processes, model mixture, thiotriazoline, decamethoxinumAbstract
Today, diseases caused by pathogenic bacteria are the most dangerous, as they can not only affect the quality of human life, but also lead to death.
According to the WHO, pathogenic bacteria namely, mycoses affect from 1/5 to 1/3 of the world's population, more than a third (37.8 %) of them cause yeast-like (Candida). Over the past 20 years, there has been a 15-fold increase in the frequency of infectious inflammatory diseases of candidiasis etiology.
After examining the range of drugs on the pharmaceutical market of Ukraine and abroad, it was found that the following drugs of foreign origin are currently used for the treatment of these diseases: Methyluracil (Lekhim, Ukraine), Solkoseril (Birsfelden, Switzerland), Mexidol (PHARMASOFT, Moscow, RF).
Based on the above it is seen that the range of drugs for the treatment of oral mucosa diseases is limited. All of the above shows the need for the creation of a new domestic drug exhibiting antimicrobial, fungicidal, reparative activity.
The aim of our work is to create a new drug based on the model mixture of Thiotriazoline and Decamethoxinum, which exhibit antimicrobial, fungicidal, repertoire activity.
Materials and methods. Thiotriazoline, decamethoxinum, model mixture. The studies were carried out by agar diffusion (well method) to study antimicrobial activity. Model mixtures with decamethoxinum were made from 0.5 to 5 mg; thiotriazoline – 200 mg. Antimicrobial activity of these model mixtures was carried out.
Results. The model mixture of thiotriazoline and decamethoxinum in antimicrobial and fungicidal action was significantly superior to decamethoxinum by 54 % in the degree of growth inhibition of S. aureus, by 120 % in the degree of growth inhibition of E. coli, by 57 % in the degree of growth inhibition of P. aeruginosa, and by 108 % in the degree of growth retardation of C. albicans at 106 CFU/ml of medium.
Conclusion. The model mixture of thiotriazoline and decamethoxinum exhibits high antimicrobial and fungicidal activity.
References
Danilevskii, N. F., & Borisenko, A. V. (2000). Zabolevaniya parodonta [Periodontal disease]. Kiev : Zdorov'e. [in Russian].
Mazur, I., Peredrii, V., & Dulko, S. (2010). Farmakolohichni zasoby dlia mistsevoho likuvannia tkanyn parodontu [Pharmacological chemicals for the local treatment of periodontal tissues]. Sovremennaya stomatologiya, (5), 47-52. [in Ukrainian].
Borisenko, A. V. (2013). Zabolevaniya parodonta [Periodontal disease]. Kiev: Meditsina. [in Russian].
Petersen, P. E. (2003). The World Oral Health Report 2003: continuous improvement of oral health in the 21st century - the approach of the WHO Global Oral Health Programme. Community Dentistry and Oral Epidemiology, 31, 3-23. https://doi.org/10.1046/j..2003.com122.x
Mossey, P. A., & Modell, B. (2012). Epidemiology of Oral Clefts 2012: An International Perspective. Cleft Lip and Palate: Epidemiology, Aetiology and Treatment, 16, 1-18. https://doi.org/10.59/000337464
Glendor, U. (2009). Aetiology and risk factors related to traumatic dental injuries--a review of the literature. Dental traumatology, 25(1), 19-31. https://doi.org/10./j.1600-9657.2008.00694.x
Petersen, P. E., Bourgeois, D., Ogawa, H., Estupinan-Day, S., & Ndiaye, C. (2005). The global burden of oral diseases and risks to oral health. Bulletin of the World Health Organization, 83(9), 661-669. https://doi.org//S0042-968620050009000
Gozhaya, I. N. (2012). Risk razvitiya zabolevanii parodonta pri nalichii khronicheskikh sotsial'nykh stressov u klinicheski zdorovykh lits [The risk of developing periodontal disease in the presence of chronic social stress in clinically healthy individuals]. Parodontologiya, (1), 21-25. [in Russian].
Tsepov, L. M., Goleva, N. A., & Nesterova, M. M. (2010). Khronicheskii generalizovannyi parodontit: ot patogeneza k lecheniyu [Chronic generalized periodontitis: from pathogenesis to treatment]. Dental Yug, (9), 32-34. [in Russian].
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
